Showing results (631-640 of 813) with videos related to
Sort By:
Pageof 82
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2020
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertensionBernhard Scheiner, Albert F Stättermayer, Philipp Schwabl, et al.Trials|August 6, 2015
The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trialMaria Luger, Renate Kruschitz, Rodrig Marculescu, et al.Journal of Personalized Medicine|April 30, 2021
Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVRGeorg Semmler, Teresa Binter, Karin Kozbial, et al.Hepatology (Baltimore, Md.)|March 31, 2021
The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist MortalityPatrick Starlinger, Joseph C Ahn, Aidan Mullan, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 12, 2022
Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patientsLukas Hartl, Katharina Haslinger, Martin Angerer, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.JHEP Reports : Innovation in Hepatology|July 18, 2022
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation eventLorenz Balcar, Marta Tonon, Georg Semmler, et al.United European Gastroenterology Journal|November 25, 2025
Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver-Related DeathCaroline Schwarz, Andrea Kornfehl, Reema Abid, et al.Biomedicines|January 13, 2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH ModelPhilipp Schwabl, Eva Hambruch, Grant R Budas, et al.Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.Pageof 82